New Zealand markets open in 2 hours 8 minutes

Edwards Lifesciences Corporation (EW)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
84.87+0.57 (+0.68%)
As of 03:52PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
1,413,800
1,402,400
1,521,900
1,503,100
823,400
Depreciation & amortisation
148,200
144,900
139,600
134,800
107,200
Deferred income taxes
-256,100
-272,100
-254,500
-41,400
-49,400
Stock-based compensation
145,100
139,400
126,800
109,300
92,600
Change in working capital
-928,700
-526,300
-421,400
145,300
42,200
Inventory
-325,700
-289,000
-213,400
19,000
-120,600
Accounts payable
102,100
146,000
-21,400
195,200
-84,500
Other working capital
251,200
629,500
953,400
1,402,300
647,000
Other non-cash items
9,700
10,400
-800
-86,200
59,500
Net cash provided by operating activities
528,200
895,800
1,218,200
1,732,100
1,054,300
Cash flows from investing activities
Investments in property, plant and equipment
-277,000
-266,300
-264,800
-329,800
-407,300
Acquisitions, net
46,000
-95,200
0
0
0
Purchases of investments
-88,200
-105,500
-778,900
-1,892,400
-861,700
Sales/maturities of investments
618,500
715,800
1,359,100
529,200
777,000
Other investing activities
-62,900
-75,000
-63,100
-29,500
-39,100
Net cash used for investing activities
236,400
173,800
252,300
-1,722,500
-531,100
Cash flows from financing activities
Debt repayment
-
-300
-200
-7,000
-17,000
Common stock repurchased
-630,500
-879,600
-1,727,100
-512,800
-625,400
Other financing activities
-2,000
-1,000
-3,600
-300
-1,200
Net cash used provided by (used for) financing activities
-442,700
-711,000
-1,584,500
-356,300
-486,900
Net change in cash
352,600
375,400
-94,800
-332,800
15,800
Cash at beginning of period
876,400
772,600
867,400
1,200,200
1,184,400
Cash at end of period
1,198,300
1,148,000
772,600
867,400
1,200,200
Free cash flow
Operating cash flow
528,200
895,800
1,218,200
1,732,100
1,054,300
Capital expenditure
-277,000
-266,300
-264,800
-329,800
-407,300
Free cash flow
251,200
629,500
953,400
1,402,300
647,000